Trials / Completed
CompletedNCT02087904
A Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
A Phase 2a Study Evaluating the Safety, Efficacy, and Pharmacodynamic Effects of ABT-981 in Patients With Knee Osteoarthritis
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 350 (actual)
- Sponsor
- AbbVie · Industry
- Sex
- All
- Age
- 35 Years – 74 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 2a, multicenter, randomized, double-blind, parallel group, placebo-controlled study to evaluate the safety, tolerability, efficacy and pharmacokinetic/pharmacodynamic effect of ABT-981 in patients with symptomatic, radiographic, and inflammatory knee osteoarthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ABT-981 | |
| OTHER | Placebo |
Timeline
- Start date
- 2014-06-04
- Primary completion
- 2016-06-07
- Completion
- 2016-12-13
- First posted
- 2014-03-14
- Last updated
- 2019-08-28
- Results posted
- 2019-08-28
Source: ClinicalTrials.gov record NCT02087904. Inclusion in this directory is not an endorsement.